title: Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.
authors.affiliation: Department of Clinical Pharmacology, Mannheim, Germany. job.harenberg@medma.uni-heidelberg.de
authors.forename: J
authors.initials: J
authors.lastname: Harenberg
authors.forename: S
authors.initials: S
authors.lastname: Marx
authors.forename: C
authors.initials: C
authors.lastname: Weiss
authors.forename: R
authors.initials: R
authors.lastname: Krämer
authors.forename: M
authors.initials: M
authors.lastname: Samama
authors.forename: S
authors.initials: S
authors.lastname: Schulman
mesh_terms: D000925:Anticoagulants / Q000097:blood / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests / Q000592:standards*; D002138:Calibration; D002863:Chromogenic Compounds / Q000592:standards; D016903:Drug Monitoring / Q000592:standards*; D065427:Factor Xa Inhibitors; D006801:Humans; D009025:Morpholines / Q000097:blood / Q000494:pharmacology*; D015588:Observer Variation; D011237:Predictive Value of Tests; D011517:Prothrombin Time / Q000592:standards; D012015:Reference Standards; D015203:Reproducibility of Results; D000069552:Rivaroxaban; D013876:Thiophenes / Q000097:blood / Q000494:pharmacology*
chemical_list: D000925:Anticoagulants; D002863:Chromogenic Compounds; D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban